Physician profile
Nicholas J Panetta
NPI 1649402439
$23,333.66
in general payments reported to CMS, 2019-2025
12 companies · $20K in 2025
The $20K reported for 2025 was more than what 97% of Plastic and Reconstructive Surgery providers received nationally (typical 2025 total: $445).
See the full distribution for Plastic and Reconstructive Surgery
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $31.33 · 2020: $55.88 · 2021: $753 · 2022: $578 · 2023: $845 · 2024: $1,015 · 2025: $20K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $18K · Food and Beverage: $2,463 · Travel and Lodging: $1,933.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $17,520.00 |
| Food and Beverage | $2,462.88 |
| Travel and Lodging | $1,932.71 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Ethicon INC. | $19,306.32 | 2025 | |
| Sientra, INC. | $1,269.66 | 2020-2022 | |
| Integra Lifesciences Corporation | $813.56 | 2023-2025 | Integra, Integra Dermal Regeneration Template, Surgimend |
| Polynovo North America LLC | $641.43 | 2024-2025 | Novosorb Btm |
| Medical Microinstruments, INC. | $406.34 | 2024 | Symani Surgical Systems |
| Mentor Worldwide LLC | $319.24 | 2020-2024 | Mentor Memorygel Resterilizable Gel Sizer, Artoura Breast Tissue Expander |
| Tela Bio, INC. | $264.94 | 2023-2025 | Ovitex Reinforced Bioscaffold With Permanent Polymer (Ovitex) |
| Kci USA, INC. | $157.49 | 2023 | Prevena, V.A.C. Veraflo Cleanse Choice |
| Baxter Healthcare | $109.35 | 2025 | Tisseel |
| W. L. Gore & Associates, INC. | $19.94 | 2019 | |
| Medela LLC | $14.00 | 2020 | |
| Allergan, INC. | $11.39 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Nicholas Panetta listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.